DOLLY PARTON RETURNS TO PUBLIC EYE TO CELEBRATE OPENING DAY AT DOLLYWOOD . (PHOTO).

Image
 Dolly Parton returns to public eye to celebrate opening day at Dollywood     Dolly Parton made her first public appearance in months to celebrate the opening day of Dollywood in Pigeon Forge, Tennessee, on Friday. The country music icon reflected on the past year, a year after the death of her husband of nearly 60 years, Carl Dean, saying she is “doing good” and has been working to rebuild herself spiritually, emotionally, and physically after grieving and dealing with health issues that kept her from touring. Joined on stage by Dollywood president Eugene Naughton, Parton brought her trademark humor to the crowd, joking about rumors of a new husband while reaffirming her devotion to Dean. She also shared updates on her ongoing projects, including a new Broadway musical and her Dolly’s Life of Many Colors Museum in Nashville. Parton previewed the park’s 41st season, highlighting the upcoming NightFlight Expedition ride, a new “Run Dollywood” race weekend, an updated ...

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.